Want to see ASND full AI Analyst Report?
Ascendis Pharma (ASND) Q2 2025 Earnings Report
ASND Q2 2025 EPS Results
- Actual EPS
- -$0.92
- Consensus EPS
- -$1.44
- Beat/Miss
- Beat by +$0.52
- One Year Ago EPS
- -$2.13
ASND Q2 2025 Revenue Results
- Actual Revenue
- $179.14M
- Expected Revenue
- $160.81M
- Beat/Miss
- Beat by +$18.33M
- YoY Revenue Growth
- +362.23%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/07/2025
- Time
- After Close
- Conference Call
- Thursday, August 7, 2025
ASND Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
ASND Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
ASND Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | 0.88- | -1.12 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 1.673.16 | -0.92 | 445.12% (+4.08) | |
| May 07, 2026 | 2026 (Q1) | 0.1810.89 | -1.76 | 717.09% (+12.65) | |
| Feb 11, 2026 | 2025 (Q4) | -0.09-0.61 | -0.71 | 14.06% (+0.10) | |
| Nov 12, 2025 | 2025 (Q3) | -0.27-1.12 | -1.92 | 41.86% (+0.80) | |
| Aug 07, 2025 | 2025 (Q2) | -1.44-0.92 | -2.13 | 57.07% (+1.22) | |
| May 01, 2025 | 2025 (Q1) | -1.64-1.76 | -2.57 | 31.30% (+0.80) | |
| Feb 12, 2025 | 2024 (Q4) | -1.10-0.71 | -1.72 | 58.44% (+1.01) | |
| Nov 14, 2024 | 2024 (Q3) | -1.75-1.92 | -3 | 36.06% (+1.08) | |
| Sep 03, 2024 | 2024 (Q2) | -1.63-2.13 | -2.41 | 11.57% (+0.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed